Harnessing Stem Cells to Treat Disease

In this webinar, Kim Vanuytsel and Ryan Flannigan will discuss cutting-edge technologies for improving stem cell-based therapies.

Event Details:Harnessing Stem Cells to Treat DiseaseDate(s):

This webinar will be hosted live and available on-demand

Tuesday, August 9, 2022
3:00 - 4:30 PM Eastern Time

Register Now

Thanks to advances in techniques for culturing and genetically modifying patient cells, scientists developed myriad stem cell-based treatments for human diseases. Therapeutic success rates for stem cell-based treatments depend on whether scientists can provide the proper structural and molecular cues to form the cell types lacking in patients. In addition, to support successful engraftment, researchers must devise ways to bypass immune rejection.

In this webinar brought to you by The Scientist’s Creative Services Team, Kim Vanuytsel and Ryan Flannigan discuss the cutting-edge technologies they incorporate to improve stem cell-based therapies for various disorders, including cancer and infertility.

Topics to be covered

Register Now

Meet the Speakers:

Kim Vanuytsel, PhD
Research Assistant Professor
Department of Medicine
Center for Regenerative Medicine
Boston University School of Medicine

Ryan Flannigan, MDAssistant ProfessorDepartment of Urologic SciencesUniversity of British ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies